Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) EBT Margin: 2015-2023

Historic EBT Margin for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -9,114.84%.

  • Cellectis' EBT Margin rose 423945.00% to -9,114.84% in Q3 2023 from the same period last year, while for Sep 2023 it was -245.16%, marking a year-over-year increase of 15292.00%. This contributed to the annual value of -314.04% for FY2022, which is 22749.00% down from last year.
  • Latest data reveals that Cellectis reported EBT Margin of -9,114.84% as of Q3 2023, which was down 622.86% from 1,743.26% recorded in Q2 2023.
  • Cellectis' 5-year EBT Margin high stood at 1,743.26% for Q2 2023, and its period low was -13,354.29% during Q3 2022.
  • Moreover, its 3-year median value for EBT Margin was -378.76% (2022), whereas its average is -3,265.53%.
  • In the last 5 years, Cellectis' EBT Margin tumbled by 1,284,456bps in 2022 and then surged by 423,945bps in 2023.
  • Quarterly analysis of 5 years shows Cellectis' EBT Margin stood at -870.34% in 2019, then skyrocketed by 58,340bps to -286.94% in 2020, then skyrocketed by 20,827bps to -78.67% in 2021, then surged by 417bps to -74.50% in 2022, then soared by 423,945bps to -9,114.84% in 2023.
  • Its EBT Margin stands at -9,114.84% for Q3 2023, versus 1,743.26% for Q2 2023 and -12,574.82% for Q1 2023.